Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment. Issue 5 (4th April 2016)

• Record Type: Journal Article
• Authors: Hexner, Elizabeth O.; Luger, Selina M.; Reshef, Ran; Jeschke, Grace R.; Mangan, James K.; Frey, Noelle V.; Frank, Dale M.; Richman, Lee P.; Vonderheide, Robert H.; Aqui, Nicole A.; Rosenbach, Misha; Zhang, Yi; Chew, Anne; Loren, Alison W.; Stadtmauer, Edward A.; Levine, Bruce L.; June, Carl H.; Emerson, Stephen G.; Porter, David L.
• Is Part Of: American journal of hematology. Volume 91:Issue 5(2016:May)
• Page Start: 453
• Page End: 460
• Publication Date: 2016-04-04
• Subjects: Hematology -- Periodicals; 616.15
• DOI: 10.1002/ajh.24303
• Languages: English
• ISSNs: 0361-8609

Abstract

Abstract : Limited cell numbers in umbilical cord blood (UCB) grafts present a major impediment to favorable outcomes in adult transplantation, largely related to delayed or failed engraftment. The advent of UCB transplantation (UCBT) using two grafts successfully circumvents this obstacle, despite the engraftment of only one unit. Preclinical models suggested that the addition of UCB T cells at the time of transplant can enhance engraftment. We tested whether ex vivo activation by CD3/CD28 costimulation and expansion of T cells from a single UCB graft would be safe and feasible in adults with advanced hematologic malignancies, with an overall objective of optimizing engraftment in single unit UCBT. In this phase 1 study, recipients of single UCB units were eligible if the unit was stored in two adequate fractions. Dose limiting toxicity was defined as grade 3 or grade 4 GVHD within 90 days of UCBT. Four patients underwent UCBT; all were treated at the first dose level (10 5 cells/kg). At the 10 5 cells/kg dose level two subjects experienced grade 3 intestinal GVHD, thus meeting stopping criteria. For three subjects, neutrophil engraftment was early (12, 17, and 20 days), while one subject experienced primary graft failure. We observed early donor T cell trafficking and found that expanded T cells produced supraphysiologic levels of cytokines relevant to engraftment and to lymphoid differentiation and function. Taken together, these preliminary data suggest rapid engraftment in recipients of a single UCBT combined with relatively low doses of activated T cells, though potentially complicated by severe GVHD. Am. J. Hematol. 91:453–460, 2016. © 2016 Wiley Periodicals, Inc.